According to Alembic Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โน27.79. In 2022 the company made an earnings per share (EPS) of โน11.06 a decrease over its 2021 EPS that were of โน41.85.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน26.88 | 143.06% |
2022 | โน11.06 | -73.58% |
2021 | โน41.85 | -38.83% |
2020 | โน68.42 | 46.76% |
2019 | โน46.62 | 30.23% |
2018 | โน35.80 | 24.72% |
2017 | โน28.70 | 6.71% |
2016 | โน26.90 | -43.88% |
2015 | โน47.93 | 138.06% |
2014 | โน20.13 | 23% |
2013 | โน16.37 |